Gilad Oren
SEC CIK 1929300 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| APRE | Aprea Therapeutics, Inc. | Pres, CEO, Dir | 393.9K | $55.4K | — | 12 | 2022-07-28 | 2026-03-12 |
Most active insiders at APRE, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Duey Marc | Dir | $25.1K | — |
| 2 | Gilad Oren | Pres, CEO, Dir | $25.0K | — |
| 3 | Hamill John P. | CFO, SrVP, Prin Fin, Acct Ofcr | $10.9K | — |
| 4 | Pamukcu Rifat | Dir | — | — |
| 5 | Gruia Gabriela | Dir | — | — |
| 6 | Seizinger Bernd R. | Dir | — | — |
| 7 | Grissinger Michael | Dir | — | — |
| 8 | Peters Richard | Dir | — | — |
| 9 | BIZZARI JEAN-PIERRE | Dir | — | — |
| 10 | HENNEMAN JOHN B III | Dir | — | — |
Transactions 12
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-03-16 | 2026-03-12 | APRE | Aprea Therapeutics, Inc. | Gilad Oren | Pres, CEO, Dir | A - Grant | $0.00 | +20.2K | 393.9K | +5% | $0 |
| D | 2026-02-02 | 2026-01-30 | APRE | Aprea Therapeutics, Inc. | Gilad Oren | Pres, CEO, Dir | P - Purchase | $0.89 | +28.1K | 373.7K | +8% | +$25.0K |
| M | 2025-04-04 | 2025-04-03 | APRE | Aprea Therapeutics, Inc. | Gilad Oren | Pres, CEO, Dir | P - Purchase | $1.84 | +5,500 | 343.1K | +2% | +$10.1K |
| D | 2025-03-31 | 2025-03-27 | APRE | Aprea Therapeutics, Inc. | Gilad Oren | Pres, CEO, Dir | A - Grant | $0.00 | +6,725 | 340.1K | +2% | $0 |
| 2024-10-24 | 2024-10-23 | APRE | Aprea Therapeutics, Inc. | Gilad Oren | Pres, CEO, Dir | P - Purchase | $3.92 | +500 | 333.4K | +0.2% | +$1,960 | |
| 2024-10-16 | 2024-10-15 | APRE | Aprea Therapeutics, Inc. | Gilad Oren | Pres, CEO, Dir | P - Purchase | $2.90 | +250 | 332.9K | +0.1% | +$725 | |
| M | 2024-10-15 | 2024-10-10+ | APRE | Aprea Therapeutics, Inc. | Gilad Oren | Pres, CEO, Dir | P - Purchase | $2.58 | +1,150 | 332.6K | +0.3% | +$2,971 |
| D | 2024-03-28 | 2024-03-28 | APRE | Aprea Therapeutics, Inc. | Gilad Oren | Pres, CEO, Dir | A - Grant | $0.00 | +6,725 | 331.5K | +2% | $0 |
| D | 2024-03-14 | 2024-03-13 | APRE | Aprea Therapeutics, Inc. | Gilad Oren | Pres, CEO, Dir | P - Purchase | $7.29 | +2,000 | 324.8K | +0.6% | +$14.6K |
| D | 2023-03-13 | 2022-08-23 | APRE | Aprea Therapeutics, Inc. | Gilad Oren | Pres, CEO, Dir | C - Cnv Deriv | $0.00 | +6.05M | 6.38M | +1,830% | $0 |
| D | 2023-03-13 | 2023-03-09 | APRE | Aprea Therapeutics, Inc. | Gilad Oren | Pres, CEO, Dir | A - Grant | $0.00 | +4,000 | 322.8K | +1% | $0 |
| D | 2022-08-01 | 2022-07-28 | APRE | Aprea Therapeutics, Inc. | Gilad Oren | Pres, CEO | A - Grant | $0.00 | +101.3K | 330.3K | +44% | $0 |
Purchase Sale Sale after option exercise All abbreviations